Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4611 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
InChI
InChIKey=MKPDWECBUAZOHP-AFYJWTTESA-N
InChI=1S/C22H29FO5/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-20(15,2)19(13)17(26)9-21(14,3)22(11,28)18(27)10-24/h4-5,7,11,13-14,16-17,19,24,26,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20+,21+,22+/m1/s1
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4611 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Paramethasone is a glucocorticoid. It exerts anti-inflammatory and immunosuppressant actions. Paramethasone stimulates the synthesis of enzymes needed to decrease anti-inflammatory response. It suppresses the immune system by reducing activity and volume of the lymphatic system, thus producing lymphocytopenia decreasing passage of immune complexes and possibly by depressing reactivity of tissue to antigen-antibody interactions.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:19 GMT 2025
by
admin
on
Mon Mar 31 17:58:19 GMT 2025
|
Record UNII |
VFC6ZX3584
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QH02AB05
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
||
|
WHO-ATC |
H02AB05
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C66309
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
m8403
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB01384
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
100000082771
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
VFC6ZX3584
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
SUB09614MIG
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
D010248
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
PARAMETHASONE
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
5875
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL1200342
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
DTXSID3023421
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
7910
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | RxNorm | ||
|
200-169-2
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
3376
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
1096
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY | |||
|
53-33-8
Created by
admin on Mon Mar 31 17:58:19 GMT 2025 , Edited by admin on Mon Mar 31 17:58:19 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |